Testing effectiveness (Phase 2)Study completedNCT03548467
What this trial is testing
Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer
Who this might be right for
Locally Advanced or Metastatic Solid Tumours
Nykode Therapeutics ASA 41